Effectiveness of combining continuous cerebrospinal drainage and intermittent intrathecal urokinase injection therapy in preventing symptomatic vasospasm following aneurysmal subarachnoid haemorrhage

British Journal of Neurosurgery

Volumn 22, Issue 5, 2008, Pages 649-653

  Yamada, Kiyofumi ^a   Yoshimura, Shinichi ^a   Enomoto, Yukiko ^a   Yamakawa, Haruki ^a   Iwama, Toru ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Intrathecal infusion; Subarachnoid haemorrhage; Urokinase; Vasospasm

Indexed keywords

ANTIBIOTIC AGENT; FASUDIL; PAPAVERINE; UROKINASE;

ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; BRAIN ANGIOGRAPHY; BRAIN ARTERY ANEURYSM; BRAIN VASOSPASM; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; FIBRINOLYTIC THERAPY; GLASGOW OUTCOME SCALE; HUMAN; MALE; NEUROSURGERY; OCCLUSIVE CEREBROVASCULAR DISEASE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

CEREBROSPINAL FLUID; COMBINED MODALITY THERAPY; DRAINAGE; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; INJECTIONS, SPINAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASOSPASM, INTRACRANIAL;

EID: 56549085721     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690802256373     Document Type: Article

References (24)

1. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9.
2. Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004;101:255-61.
3. Kinouchi H, Ogasawara K, Shimizu H, Mizoi K, Yoshimoto T. Prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage by intraoperative cisternal fibrinolysis using tissue-type plasminogen activator combined with continuous cisternal drainage. Neurol Med Chir (Tokyo) 2004;44:569-77.
4. Ljunggren B, Saveland H, Brandt L, Zygmunt S. Early operation and overall outcome in aneurysmal subarachnoid hemorrhage. J Neurosurg 1985;62:547-51.
5. Mizukami M, Kawase T, Usami T, Tazawa T. Prevention of vasospasm by early operation with removal of subarachnoid blood. Neurosurgery 1982;10:301-7.
6. Taneda M. Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms. J Neurosurg 1982;57:622-8.
7. Usui M, Saito N, Hoya K, Todo T. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone. Neurosurgery 1994;34:235-345.
8. Inagawa T, Kamiya K, Matsuda Y. Effect of continuous cisternal drainage on cerebral vasospasm. Acta Neurochir (Wien) 1991;112:28-36.
9. Ito U, Tomita H, Yamazaki S, Yamazaki S, Takada Y, Inaba Y. Enhanced cisternal drainage and cerebral vasospasm in early aneurysm surgery. Acta Neurochir 1986;80:18-23.
10. Kasuya H, Shimizu T, Kagawa M. The effect of continuous drainage of cerebrospinal fluid in patients with subarachnoid hemorrhage: a retrospective analysis of 108 patients. Neurosurgery 1991;28:56-9.
11. Kawakami Y, Shimamura Y. Cisternal drainage after early operation of ruptured intracranial aneurysm. Neurosurgery 1987;20:8-14.
12. Klimo P, Kestle JRW, Macdonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebroapinal fluid after subarachnoid hemorrhage. J Neurosurg 2004;100:215-24.
13. Sakaki S, Ohta S, Kuwabara H, Shiraishi M. The role of ventricular and cisternal drainage in the early operation for ruptured intracranial aneurysms. Acta Neurochir (Wien) 1987;88:87-94.
14. Kodama N, Sasaki T, Kawakami M, Sato M, Asari J. Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm after aneurysmal subarachnoid hemorrhage. Outcome in 217 patients. Surg Neurol 2000;53:110-18.
15. Ohman J, Servo A, Heiskanen O. Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 1991;75:197-201.
16. Sasaki T, Ohta T, Kikuchi H, et al. A phase α clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 1994;35:597-605.
17. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848-52.
18. Findlay JM. Current management of cerebral vasospasm. Contemp Neurosurg 1997;19:1-6.
19. Jito J, Nakasu Y, Nakasu S, Hatsuda N, Matsuda M. Tissue plasminogen activator levels after single intracisternal injection in patients with subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 2004;44:55-60.
20. Sasaki T, Kodama N, Kawakami M, et al. Urokinase cisternal irrigation therapy for prevention of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000;31:1256-62.
21. Hamada J, Kai Y, Morioka M, et al. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna. Stroke 2003;34:2549-54.
22. Kawamoto S, Tsutsumi K, Yoshikawa G, et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2004;100:236-43.
23. Mizuno T, Hamada J, Kai Y, et al. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs. Am J Neuroradiol 2003;24:613-18.
24. Moriyama E, Matsumoto Y, Meguro T, et al. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1995;35:732-6.